United States — Food and Drug Administration & Democratic Republic of the Congo
4 shared events · Importance 3 · Last updated Jun 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Accidents
United States — Food and Drug Administration: The United States — Food and Drug Administration has approved Inmazeb, a combination of antibodies, to treat Zaire Ebolavirus infection, which Regeneron Pharmaceuticals has donated for potential use in the current outbreak.
Democratic Republic of the Congo: The Democratic Republic of the Congo>>> is the epicenter of the current Ebola outbreak, with hundreds of suspected cases and deaths, facing significant challenges in containment due to conflict, weak health infrastructure, and public mistrust.
May 18, 2026 · 505 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body that Revolution Medicines will seek approval from for its experimental pancreatic cancer drug, daraxonrasib.
Democratic Republic of the Congo: The Democratic Republic of the Congo is experiencing a severe Ebola outbreak with over 100 deaths, complicated by conflict and challenges in response efforts.
May 18, 2026 · 243 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Democratic Republic of the Congo interact across events, view sentiment trends, and discover connected entities.
Open Dashboard